Medioath Pharmaceuticals Private Limited

Medioath Pharmaceuticals Private Limited - food and beverages in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304MH2020PTC346230 Incorporated 17 September 2020 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company food and beverages MSME · Micro
Data last updated
Revenue · FY 2025
₹22.42 Lakh
▼ 29% YoY
Net loss · FY 2025
₹5.51 Lakh
Net margin -24.6%
EBITDA · FY 2025
-₹7.44 Lakh
EBITDA margin -33.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medioath Pharmaceuticals Private Limited

Data last updated:

Medioath Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 17 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2020PTC346230. Its GSTIN is 09AAOCM1459N1ZQ (Uttar Pradesh).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Minakshi Kaira and Renu Singh Kaira.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 3 Ground Floor Building No 26 – B Rajdeep Brindavan Chs Ltd, Brindavan Complex Thane West, Maharashtra, India – 400601.

As per the financials filed for FY 2025, the company reported a revenue of ₹22.42 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹5.51 Lakh (net margin -24.6%) and EBITDA of -₹7.44 Lakh (EBITDA margin -33.2%). Revenue has grown at a compounded annual rate (CAGR) of 136% over three years.

Medioath Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0010509). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304MH2020PTC346230
Registration Number 346230
Incorporation Date 17 September 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0010509
Key People
Minakshi Kaira Director Renu Singh Kaira Director

Recognitions & Rankings of Medioath Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-UP-50-0010509

Contact details

Medioath Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Flat No 3 Ground Floor Building No 26 – B Rajdeep Brindavan Chs Ltd, Brindavan Complex Thane West, Maharashtra, India – 400601
  • Industry
    Food And Beverages, Artificial Fibres, Manufacturing

To see the full contact details of Medioath Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medioath Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medioath Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Medioath Pharmaceuticals Private Limited, buy the company report.

Financials of Medioath Pharmaceuticals Private Limited

FY 2025 filings available

Medioath Pharmaceuticals Private Limited reported revenue of ₹22.42 Lakh (down 29% YoY) for FY 2025.

Revenue · FY 2025
₹22.42 Lakh ▼ 29%
Net loss · FY 2025
₹5.51 Lakh margin -24.6%
EBITDA · FY 2025
-₹7.44 Lakh margin -33.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 136%
EBITDA CAGR growth
1 year
▼ 113%
3 years · compounded
▼ 28%

Revenue fell 29% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 136%. EBITDA fell 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7.44 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.51 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-33.2%
Net Profit Margin-24.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medioath Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medioath Pharmaceuticals Private Limited

Medioath Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Minakshi KairaDirector06 Aug 20233 Years 2 MonthsCurrent
Renu Singh KairaDirector30 Aug 20215 Years 2 MonthsCurrent
View all directors

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medioath Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Medioath Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.

Active EPFO establishments
1

GST

Medioath Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAOCM1459N1ZQUttar PradeshActive12 Aug 2021

To see the full GST registrations and return filing status of Medioath Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medioath Pharmaceuticals Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Manish Kumar Pathak ceased to be Director on 06 Aug 2023.

AGM
Medioath Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medioath Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Manish Kumar Pathak ceased to be Director.
Appointed
Minakshi Kaira was appointed as Director.
Ceased
Champa Kaida ceased to be Director.
Ceased
Chander Singh Kaira ceased to be Director.
Appointed
Renu Singh Kaira was appointed as Director.
Incorporation
17 Sep 2020
Medioath Pharmaceuticals Private Limited was registered on 17 Sep 2020 with Roc Mumbai Ii & aged 6 years 1 month as per MCA records.

Frequently asked questions

Medioath Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 17 September 2020 (6+ years old) and is registered under CIN U24304MH2020PTC346230.

Medioath Pharmaceuticals has 2 current directors:

The latest financial statements of Medioath Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Medioath Pharmaceuticals is 09AAOCM1459N1ZQ, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Medioath Pharmaceuticals is U24304MH2020PTC346230. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medioath Pharmaceuticals was incorporated on 17 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

Manish Kumar Pathak ceased to be Director on 06 Aug 2023. Minakshi Kaira was appointed as Director on 06 Aug 2023. Champa Kaida ceased to be Director on 03 Nov 2022. Medioath Pharmaceuticals has 5 board changes on record in total.

Yes, Medioath Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0010509).

The registered office of Medioath Pharmaceuticals is at Flat No 3 Ground Floor Building No 26 – B Rajdeep Brindavan Chs Ltd, Brindavan Complex Thane West, Maharashtra, India – 400601.

Medioath Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.